NCT05173337View on ClinicalTrials.gov

Nefopam as a Multimodal Analgesia for Thoracic Surgery

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 8, 2021

Primary Completion Date

September 23, 2022

Study Completion Date

September 23, 2022

Conditions
Lung Cancer
Interventions
DRUG

Nefopam

"Nefopam 20 mg is mixed to 100 mL of normal saline, and is infused intravenously over 15 minutes.~20 mg of nefopam is administered intravenously for two times, after induction and at the end of surgery."

Trial Locations (1)

03181

Eunah Cho, Seoul

All Listed Sponsors
lead

Kangbuk Samsung Hospital

OTHER